Biocept Expands Blood-Based Test To Identify Key Biomarkers For Non-Small Cell and Small Cell Lung Cancers
Lung Cancer, News
Biocept, Inc., a molecular diagnostics firm that commercializes and develops liquid biopsies in order to improve both treatment and detection of cancer, recently announced the launch of the FGFR1 amplification test that ... Read more